Thursday 18 December 2014

GlaxoSmithKline shingles vaccine hits goal in major study

LONDON (Reuters) - An experimental vaccine against shingles from GlaxoSmithKline met its goal in a late-stage study, in a boost for the company's vaccine unit, which is expanding part of its overall healthcare business.


via Reuters: Health News Read More Here..

No comments:

Post a Comment